Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants

被引：0
|
作者：
Tacke, F
Gehrke, C
Heim, A
Manns, MP
Trautwein, C
机构：
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
[2] Hannover Med Sch, Dept Virol, D-3000 Hannover, Germany
来源：
JOURNAL OF HEPATOLOGY | 2004年 / 40卷
关键词：
D O I：
10.1016/S0168-8278(04)90055-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
55
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] Variability in the Precore and Core Promoter Region of the Hepatitis B Virus Genome
    Nordin, Maria
    Ingman, Mikael
    Lindqvist, Beata
    Kidd-Ljunggren, Karin
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (03) : 437 - 445
  • [22] THE EFFECT OF PRECORE AND BASAL CORE PROMOTER MUTATIONS OF HEPATITIS B VIRUS IN VIRAL REPLICATION CONTROL AND NKG2D ACTIVATION
    Koumbi, L.
    Pollicino, T.
    Khakoo, S.
    Raimondo, G.
    Karayiannis, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S141 - S141
  • [23] SUPPORTIVE ACTIVITY OF PRECORE AND PRES2 VIRAL GENOMIC CHANGES AGAINST REPLICATION OF LAMIVUDINE-RESISTANT HEPATITIS B VIRUS
    Ohkawa, Kazuyoshi
    Takehara, Tetsuo
    Kato, Michio
    Hikito, Hayato
    Sasakawa, Akira
    Kohga, Keisuke
    Uemura, Akio
    Sakamori, Ryotaro
    Yamaguchi, Shinjiro
    Miyagi, Takuya
    Ishida, Hisashi
    Tatsumi, Tomohide
    Hayashi, Norio
    HEPATOLOGY, 2008, 48 (04) : 713A - 713A
  • [24] Mutants in the precore, core promoter, and core regions of Hepatitis B virus, and their clinical relevance
    Alexopoulou, Alexandra
    ANNALS OF GASTROENTEROLOGY, 2009, 22 (01): : 13 - 23
  • [25] Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation
    Tsai, Wei-Lun
    Lo, Gin-Ho
    Hsu, Ping-I
    Lai, Kwok-Hung
    Lin, Chiun-Ku
    Chan, Hoi-Hung
    Chen, Wen-Chi
    Cheng, Jin-Shiung
    Liu, Yung-Ching
    Huang, Tsi-Shu
    Ger, Luo-Ping
    Lin, Hsi-Hsun
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (02) : 196 - 201
  • [26] Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus
    Hosaka, T
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Someya, T
    Sezaki, H
    Akuta, N
    Tsubota, A
    Arase, Y
    Ikeda, K
    Kumada, H
    INTERVIROLOGY, 2004, 47 (06) : 362 - 369
  • [27] Predominance of precore mutations and clinical significance of basal core promoter mutations in chronic hepatitis B virus infection in Indonesia
    Juniastuti
    Utsumi, Takako
    Aksono, Eduardus Bimo
    Yano, Yoshihiko
    Soetjipto
    Hayashi, Yoshitake
    Hotta, Hak
    Rantam, Fedik Abdul
    Kusumobroto, Hernomo Ontoseno
    Lusida, Maria Inge
    BIOMEDICAL REPORTS, 2013, 1 (04) : 522 - 528
  • [28] PRECORE AND BASAL CORE PROMOTER MUTATIONS RESTORE THE REDUCED REPLICATION EFFICACY OF TENOFOVIR-RESISTANCE ASSOCIATED RTA194T POLYMERASE MUTATIONS OF THE HEPATITIS B VIRUS
    Amini-Bavil-Olyaee, Samad
    Sheldon, Julie
    Trautwein, Christian
    Tacke, Frank
    HEPATOLOGY, 2008, 48 (04) : 682A - 683A
  • [29] Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genome
    Young Min Park
    World Journal of Hepatology, 2015, (01) : 113 - 120
  • [30] Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
    Perrillo, R
    Schiff, E
    Yoshida, E
    Statler, A
    Hirsch, K
    Wright, T
    Gutfreund, K
    Lamy, P
    Murray, A
    HEPATOLOGY, 2000, 32 (01) : 129 - 134
12345